School of Public Health and Health Professions, Department of Community Health and Health Behavior, University at Buffalo, SUNY, Buffalo, New York, USA.
Population Studies Center, University of Michigan, Ann Arbor, Michigan, USA.
Cannabis Cannabinoid Res. 2023 Jun;8(3):505-509. doi: 10.1089/can.2022.0068. Epub 2022 Nov 30.
To assess the regulations on Cannabis advertising across U.S. states for variation and compare with Canadian federal policies, for the purpose of identifying opportunities to protect the public, especially the youth and other vulnerable populations, from health risks. We reviewed Health Canada's and to identify prohibited marketing and advertising activities for cannabis products. The Canadian guidelines (where cannabis is legal for both medical and nonmedical use) were compared with regulations in the 36 U.S. states where cannabis is legalized for medical and/or adult (e.g., recreational) use. Cannabis advertising regulations vary greatly and have little consistency across the U.S. states. Most states do not address many of the cannabis advertising activities that are prohibited in Canada. Among the 31 states that do allow some form of cannabis advertising, 74% explicitly prohibit targeting or appealing to minors and 68% prohibit making false or misleading claims. There are 11 illegal advertising tactics in Canada, such as glamorization and testimonials, that were not specifically discussed in any of the U.S. state policies. The lack of consistent marketing guidelines could expose youth and vulnerable populations to cannabis advertisements; more widespread or federal guidance is needed.
为了评估美国各州的大麻广告法规的变化,并与加拿大联邦政策进行比较,目的是识别保护公众,特别是青少年和其他弱势群体免受健康风险的机会。我们审查了加拿大卫生部的 和 ,以确定大麻产品的禁止营销和广告活动。将加拿大的准则(医用和非医用大麻均合法)与 36 个美国州的法规进行了比较,这些州的医用和/或成人(例如娱乐用)大麻合法化。大麻广告法规在美国各州之间差异很大,且缺乏一致性。大多数州没有涉及加拿大禁止的许多大麻广告活动。在允许某种形式的大麻广告的 31 个州中,有 74%明确禁止针对或吸引未成年人,有 68%禁止虚假或误导性声明。加拿大有 11 种非法广告策略,例如美化和推荐,这些策略在任何美国州政策中都没有具体讨论。缺乏一致的营销准则可能会使青少年和弱势群体接触到大麻广告;需要更广泛或联邦的指导。